This announcement is a separate document:
歐康維視生物-B：(I)根據2021年購股權計劃授出購股權；(II)根據2021年股份獎勵計劃向僱員授出獎勵；及(III)非豁免關連交易－建議向董事作出的關連授出
Ocumension Therapeutics-B: (I) GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME; (II) GRANT OF AWARDS TO EMPLOYEES UNDER THE 2021 SHARE AWARD SCHEME; AND (III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED CONNECTED GRANT TO DIRECTORS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.